These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 11171898)

  • 1. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.
    Mathieu J; Boivin H; Meunier D; Gaudreault M; Bégin P
    Neurology; 2001 Feb; 56(3):336-40. PubMed ID: 11171898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study.
    Rinninella E; Silvestri G; Cintoni M; Perna A; Martorana GE; De Lorenzo A; Rossini PM; Miggiano GAD; Gasbarrini A; Mele MC
    Nutrition; 2019; 67-68():110546. PubMed ID: 31376676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year study of quality of life in myotonic dystrophy.
    Peric S; Vujnic M; Dobricic V; Marjanovic A; Basta I; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Neurol Scand; 2016 Nov; 134(5):346-351. PubMed ID: 27696366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of muscular impairment rating scale with myopathological changes in myotonic dystrophy type 1].
    Wang W; Liu Q; Wang ZX; Zhang W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):508-11. PubMed ID: 23660318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
    Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
    Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective measurement of quality of life in myotonic dystrophy type 1.
    Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
    Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a disability scale for myotonic dystrophy type 1.
    Contardi S; Pizza F; Falzone F; D'Alessandro R; Avoni P; Di Stasi V; Montagna P; Liguori R
    Acta Neurol Scand; 2012 Jun; 125(6):431-8. PubMed ID: 21902674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major involvement of trunk muscles in myotonic dystrophy type 1.
    Solbakken G; Ørstavik K; Hagen T; Dietrichs E; Naerland T
    Acta Neurol Scand; 2016 Dec; 134(6):467-473. PubMed ID: 26984572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between Lower Limb Muscle Strength Impairments and Physical Limitations in DM1.
    Petitclerc É; Hébert LJ; Mathieu J; Desrosiers J; Gagnon C
    J Neuromuscul Dis; 2018; 5(2):215-224. PubMed ID: 29865087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower limb muscle magnetic resonance imaging in Chinese patients with myotonic dystrophy type 1.
    Song J; Fu J; Ma M; Pang M; Li G; Gao L; Zhang J
    Neurol Res; 2020 Feb; 42(2):170-177. PubMed ID: 31951783
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary titin in myotonic dystrophy type 1.
    Varga D; Perecz B; Fülöp K; Sipos A; Janszky JV; Hajdú N; Pál E
    Muscle Nerve; 2023 Aug; 68(2):215-218. PubMed ID: 37291994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering health and social care needs among myotonic dystrophy patients: Utility of the Needs and Provisions Complexity Scale.
    Holmøy AKT; Johannessen CH; Hope S; van Walsem MR; Aanonsen NO; Hassel B
    Acta Neurol Scand; 2019 Jun; 139(6):526-532. PubMed ID: 30848487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to capture activities of daily living in myotonic dystrophy type 2?
    Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
    Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functioning and disability in adults with myotonic dystrophy type 1.
    Kierkegaard M; Harms-Ringdahl K; Holmqvist LW; Tollbäck A
    Disabil Rehabil; 2011; 33(19-20):1826-36. PubMed ID: 21254917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ dysfunction and muscular disability in myotonic dystrophy type 1.
    Kaminsky P; Poussel M; Pruna L; Deibener J; Chenuel B; Brembilla-Perrot B
    Medicine (Baltimore); 2011 Jul; 90(4):262-268. PubMed ID: 21694643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.
    Cutellè C; Rastelli E; Gibellini M; Greco G; Frezza E; Botta A; Terracciano C; Massa R
    Neuromuscul Disord; 2018 Nov; 28(11):947-951. PubMed ID: 30270126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swallow-related quality of life and oropharyngeal dysphagia in myotonic dystrophy.
    Pilz W; Passos VL; Verdonschot RJ; Meijers J; Roodenburg N; Halmans Y; Faber CG; Kremer B; Baijens LWJ
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2357-2362. PubMed ID: 32296979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swallowing assessment in myotonic dystrophy type 1 using fiberoptic endoscopic evaluation of swallowing (FEES).
    Pilz W; Baijens LW; Passos VL; Verdonschot R; Wesseling F; Roodenburg N; Faber CG; Kremer B
    Neuromuscul Disord; 2014 Dec; 24(12):1054-62. PubMed ID: 25264166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.